???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Tiago Torres

Nomes de citação

  • Torres, Tiago

Identificadores de autor

Ciência ID
FF1B-8834-7AE0
ORCID iD
0000-0003-0404-0870

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica - Dermatologia e Doenças Venéreas

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1)
Italiano Utilizador independente (B1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador independente (B1)
Português Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Formação
Grau Classificação
2024/02
Concluído
 Titulo de agregado no ramo de conhecimento em Ciências Médicas (Título de Agregado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014
Concluído
 Ciências Médicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Importancia da Psoriase em Placas Moderada a Grave como Factor de Risco Cardiovascular: Estudo numa População Portuguesa" (TESE/DISSERTAÇÃO)
 Aprovado com distinção
2004
Concluído
 Medicina (Licenciatura)
Universidade do Porto Faculdade de Medicina, Portugal
"Curso de Medicina 98-04 - sem tese de mestrado" (TESE/DISSERTAÇÃO)
 16
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2023/01/01 - Atual Professor Associado Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2022/12 Professor Auxiliar Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015 - 2016 Professor Auxiliar Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2011/07/25 - Atual Assistente Hospitalar Graduado Dermatologia (Senior Specialist in Dermatology) Centro Hospitalar Universitário do Porto EPE, Portugal
2010 - Atual Researcher Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal
2006/03/27 - 2011/07/22 Interno de especialidade (specialty Intern) Centro Hospitalar Universitário do Porto EPE, Portugal
Projetos

Bolsa

Designação Financiadores
2022 - Atual Impacto da epigenética na psoríase e sua comparação com outras doenças inflamatórias sistémicas
1
Investigador responsável
Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal
Sociedade Portuguesa de Dermatologia e Venereologia
Em curso
2021 - Atual IO-AD: Avaliação de BIOmarcadores na Dermatite Atópica
2021
Investigador responsável
Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal
Sociedade Portuguesa de Dermatologia e Venereologia
Em curso
2019 - Atual Fatores Epigenéticos como Biomarcadores de Resposta à Terapêutica na Psoríase
z
Investigador responsável
Sociedade Portuguesa de Dermatologia e Veneorologia
Em curso
2019 - Atual Inflamação Sistémica na Dermatite Atópica - Associação com Fatores Genéticos e Epigenéticos
2019
Investigador responsável
Sociedade Portuguesa de Dermatologia e Venereologia
Em curso
2019 - Atual Epigenética e Psoriase:o papel da metilação de DNA
a
Investigador responsável
Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal
Sociedade Portuguesa de Dermatologia e Venereologia
Em curso
2017 - 2020 MicroRNAs: Avaliação de Biomarcadores na Psoríase
2017
Investigador responsável
Sociedade Portuguesa de Dermatologia e Venereologia
2013 - 2014 Estudo comparativo das comorbilidades, risco cardiovascular e aterosclerose subclínica num coorte de doente com psoríase, artrite psoriática, artrite reumatóide e espondilite anquilosante
2
Investigador responsável
Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal
Sociedade Portuguesa de Dermatologia e Venereologia
Concluído
2010 - 2014 Cardiovascular risk factors in patients with psoriasis: is there a genetic link? Can we predict who will be at risk of developing cardiovascular comorbidities?
nd
Investigador responsável
Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal
Sociedade Portuguesa de Dermatologia e Venereologia
Concluído

Projeto

Designação Financiadores
2018 - 2021 3Ds - transDermic aDministration of Drugs
FCT/ FEDER (PTDC/ QUI-COL/30834/2017
Investigador
Fundação para a Ciência e a Tecnologia
Concluído
Produções

Publicações

Artigo em revista
  1. Tiago Torres; Andrea Chiricozzi; Luis Puig; Ana Maria Lé; Angelo Valerio Marzano; Paolo Dapavo; Esteban Dauden; et al. "Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study". American Journal of Clinical Dermatology (2024): https://doi.org/10.1007/s40257-024-00845-4.
    10.1007/s40257-024-00845-4
  2. Anastasia Drakos; Tiago Torres; Ronald Vender. "Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents". Pharmaceutics (2024): https://doi.org/10.3390/pharmaceutics16010111.
    10.3390/pharmaceutics16010111
  3. Diana Bernardo; Diamant Thaçi; Tiago Torres. "Spesolimab for the Treatment of Generalized Pustular Psoriasis". Drugs (2024): https://doi.org/10.1007/s40265-023-01988-0.
    10.1007/s40265-023-01988-0
  4. Tomás Estevinho; Ana Maria Lé; Tiago Torres. "Deucravacitinib in the treatment of psoriasis". Journal of Dermatological Treatment (2023): https://doi.org/10.1080/09546634.2022.2154122.
    10.1080/09546634.2022.2154122
  5. A. Reymundo; S. Armesto; L. Rodríguez; O. Baniandrés; A. Sahuquillo-Torralba; T. Torres; P. de la Cueva; M. Llamas-Velasco; E. Daudén. "Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice". Journal of the European Academy of Dermatology and Venereology (2023): https://doi.org/10.1111/jdv.19371.
    10.1111/jdv.19371
  6. Ana Maria Lé; Melinda Gooderham; Tiago Torres. "Abrocitinib for the treatment of atopic dermatitis". Immunotherapy (2023): https://doi.org/10.2217/imt-2023-0057.
    10.2217/imt-2023-0057
  7. Tiago Torres; Jordi Galván; Nigel Crutchley; Morten Praestegaard; Lars Iversen; Paolo Gisondi; José Manuel Carrascosa; et al. "Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review". Dermatology and Therapy (2023): https://doi.org/10.1007/s13555-023-01003-0.
    10.1007/s13555-023-01003-0
  8. Anastasia Drakos; Ron Vender; Tiago Torres. "Topical roflumilast for the treatment of psoriasis". Expert Review of Clinical Immunology (2023): https://doi.org/10.1080/1744666X.2023.2219897.
    10.1080/1744666X.2023.2219897
  9. Antonio Costanzo; Akio Tanaka; Tiago Torres; Bibiana Pérez-García; Angelina Sontag; Yun-Fei Chen; Fan Emily Yang; et al. "Efficacy of baricitinib 4 mg in patients with moderate-to-severe atopic dermatitis previously treated with systemic therapy". JEADV Clinical Practice (2023): https://doi.org/10.1002/jvc2.187.
    10.1002/jvc2.187
  10. A. Reich; A. Pinter; J.-T. Maul; R. B. Vender; T. Torres; A. Brnabic; N. Haustrup; et al. "Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks". Journal of the European Academy of Dermatology and Venereology (2023): https://doi.org/10.1111/jdv.19161.
    10.1111/jdv.19161
  11. Diana Bernardo; Thomas Bieber; Tiago Torres. "Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis". American Journal of Clinical Dermatology (2023): https://doi.org/10.1007/s40257-023-00793-5.
    10.1007/s40257-023-00793-5
  12. Dea Metko; Tiago Torres; Ronald Vender. "Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?". Journal of International Medical Research (2023): https://doi.org/10.1177/03000605231175547.
    10.1177/03000605231175547
  13. Egídio Freitas; Tiago Torres. "Difamilast for the treatment of atopic dermatitis". Journal of International Medical Research (2023): https://doi.org/10.1177/03000605231169445.
    10.1177/03000605231169445
  14. Egídio Freitas; Emma Guttman-Yassky; Tiago Torres. "Baricitinib for the Treatment of Alopecia Areata". Drugs (2023): https://doi.org/10.1007/s40265-023-01873-w.
    10.1007/s40265-023-01873-w
  15. Egídio Freitas; Tiago Torres. "New molecules for atopic dermatitis treatment beyond biological therapy". Current Opinion in Allergy & Clinical Immunology 23 (2023): 210-215.
    10.1097/aci.0000000000000910
  16. García, Nuria; Guiró, Pere; Galván, Jordi; Crutchley, Nigel; Praestegaard, Morten; Iversen, Lars; Torres, Tiago. "Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp". Drugs in Context 12 (2023): 1-8. http://dx.doi.org/10.7573/dic.2023-2-8.
    10.7573/dic.2023-2-8
  17. Diogo Fonseca; Miguel Nogueira; Tiago Torres. "Upadacitinib for the treatment of psoriatic arthritis". Drugs in Context 12 (2023): 1-13.
    Acesso aberto • 10.7573/dic.2022-11-6
  18. Tiago Torres; Paulo Filipe; Francisco Menezes Brandão; Américo Figueiredo; António Pinto Soares; Artur Sousa Basto; Clarisse Rebelo; et al. "Epidemiology of Psoriasis in Portugal: A Population-Based Study". Acta Médica Portuguesa (2023): https://doi.org/10.20344/amp.19048.
    10.20344/amp.19048
  19. Quirke-McFarlane, Sophia; Weinman, John; Cook, Emma S; Yiu, Zenas Z N; Dand, Nick; Langan, Sinead M; Bechman, Katie; et al. "Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey". British Journal of Dermatology 188 5 (2022): 610-617. http://dx.doi.org/10.1093/bjd/ljac144.
    10.1093/bjd/ljac144
  20. Ana Maria Lé; Tiago Torres. "OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis—Focus on Rocatinlimab and Amlitelimab". Pharmaceutics (2022): https://doi.org/10.3390/pharmaceutics14122753.
    10.3390/pharmaceutics14122753
  21. Sofia Nogueira; Maria Alexandra Rodrigues; Ron Vender; Tiago Torres. "Tapinarof for the treatment of psoriasis". Dermatologic Therapy (2022): https://doi.org/10.1111/dth.15931.
    10.1111/dth.15931
  22. M. Augustin; P.G. Sator; R. von Kiedrowski; C. Conrad; D. Rigopoulos; M. Romanelli; P.-D. Ghislain; et al. "Secukinumab demonstrated sustained retention, effectiveness and safety in a real-world setting in patients with moderate-to-severe plaque psoriasis: long-term results from an interim analysis of the SERENA study". Journal of the European Academy of Dermatology and Venereology 36 10 (2022): 1796-1804. https://doi.org/10.1111/jdv.18329.
    10.1111/jdv.18329
  23. Reolid, Alejandra; Armesto, Susana; Sahuquillo-Torralba, Antonio; Torres, Tiago; Feltes, Rosa; Vilarrasa, Eva; Belinchón, Isabel; et al. "Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting". Journal of the American Academy of Dermatology 87 3 (2022): 705-709. http://dx.doi.org/10.1016/j.jaad.2022.05.047.
    10.1016/j.jaad.2022.05.047
  24. Torres, Tiago; Puig, Luis; Vender, Ron; Yeung, Jensen; Carrascosa, José-Manuel; Piaserico, Stefano; Gisondi, Paolo; et al. "Drug Survival of Interleukin (IL)-17 and IL-23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi-country, Multicentric Cohort Study". American Journal of Clinical Dermatology 23 6 (2022): 891-904. http://dx.doi.org/10.1007/s40257-022-00722-y.
    10.1007/s40257-022-00722-y
  25. Zitouni, J.; Bursztejn, A.-C.; Belloni Fortina, A.; Beauchet, A.; Di Lernia, V.; Lesiak, A.; Thomas, J.; et al. "Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)". Journal of the European Academy of Dermatology and Venereology 36 11 (2022): 2076-2086. http://dx.doi.org/10.1111/jdv.18361.
    10.1111/jdv.18361
  26. Maçães, Cláudia Oliveira; Lé, Ana Maria; Torres, Tiago. "Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors". Journal of Dermatological Treatment 33 7 (2022): 2911-2918. http://dx.doi.org/10.1080/09546634.2022.2089335.
    10.1080/09546634.2022.2089335
  27. Rodrigues, Maria Alexandra; Freitas, Egídio; Torres, Tiago. "Pustulose Palmo-Plantar". Acta Médica Portuguesa 36 1 (2022): 63-64. http://dx.doi.org/10.20344/amp.17018.
    10.20344/amp.17018
  28. Rodrigues, Maria Alexandra; Freitas, Egídio; Torres, Tiago. "Bimekizumab for psoriasis". Drugs of Today 58 6 (2022): 273-282. http://dx.doi.org/10.1358/dot.2022.58.6.3400572.
    10.1358/dot.2022.58.6.3400572
  29. Egídio Freitas; Melinda Gooderham; Tiago Torres. "New Topical Therapies in Development for Atopic Dermatitis". Drugs (2022): https://doi.org/10.1007/s40265-022-01722-2.
    10.1007/s40265-022-01722-2
  30. Bechman, Katie; Cook, Emma S.; Dand, Nick; Yiu, Zenas Z.N.; Tsakok, Teresa; Meynell, Freya; Coker, Bolaji; et al. "Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey". British Journal of Dermatology 187 2 (2022): 254-256. http://dx.doi.org/10.1111/bjd.21042.
    10.1111/bjd.21042
  31. van Huizen, Astrid M.; Menting, Stef P.; Gyulai, Rolland; Iversen, Lars; van der Kraaij, Gayle E.; Middelkamp-Hup, Maritza A.; Warren, Richard B.; et al. "International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis". JAMA Dermatology 158 5 (2022): 561. http://dx.doi.org/10.1001/jamadermatol.2022.0434.
    10.1001/jamadermatol.2022.0434
  32. Teixeira, Ana; Ribeiro, Cristiano; Gaio, Rita; Torres, Tiago; Magina, Sofia; Pereira, Teresa; Teixeira, Maribel; et al. "Influence of psoriasis lesions' location and severity on psychosocial disability and psychopathology. Observational study and psychometric validation of the SAPASI Portuguese version". Journal of Psychosomatic Research 154 (2022): 110714. http://dx.doi.org/10.1016/j.jpsychores.2021.110714.
    10.1016/j.jpsychores.2021.110714
  33. Torres, T.; Paiva-Lopes, M. J.; Gonçalo, M.; Claro, C.; Oliveira, M.; Gomes, J.; Vieira, A. P.; et al. "Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study". Journal of Dermatological Treatment 33 5 (2022): 2554-2559. http://dx.doi.org/10.1080/09546634.2022.2035309.
    10.1080/09546634.2022.2035309
  34. Ana Maria Lé; Tiago Torres. "New Topical Therapies for Psoriasis". American Journal of Clinical Dermatology 23 1 (2022): 13-24. https://doi.org/10.1007/s40257-021-00649-w.
    10.1007/s40257-021-00649-w
  35. Ana Maria Lé; Tiago Torres. "Correction to: New Topical Therapies for Psoriasis". American Journal of Clinical Dermatology 23 1 (2022): 25-25. https://doi.org/10.1007/s40257-021-00657-w.
    10.1007/s40257-021-00657-w
  36. Margarida Gonçalo; Tiago Torres. "A Revista da SPDV em mudança". Journal of the Portuguese Society of Dermatology and Venereology (2021): https://doi.org/10.29021/spdv.79.4.1481.
    10.29021/spdv.79.4.1481
  37. Tiago Torres; Andrea Chiricozzi; Luis Puig. "Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”". American Journal of Clinical Dermatology (2021): https://doi.org/10.1007/s40257-021-00640-5.
    10.1007/s40257-021-00640-5
  38. Nogueira, Miguel; Torres, Tiago. "Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib". Dermatology Practical & Conceptual (2021): e2021145. http://dx.doi.org/10.5826/dpc.1104a145.
    10.5826/dpc.1104a145
  39. Egídio Freitas; Andrew Blauvelt; Tiago Torres. "Bimekizumab for the Treatment of Psoriasis". Drugs (2021): https://doi.org/10.1007/s40265-021-01612-z.
    10.1007/s40265-021-01612-z
  40. Teixeira, Ana; Teixeira, Maribel; Almeida, Vera; Gaio, Rita; Torres, Tiago; Magina, Sofia; Cunha, Cátia; Sousa Lobo, José M.; Almeida, Isabel F.. "Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis". Pharmaceutics 13 10 (2021): 1539. http://dx.doi.org/10.3390/pharmaceutics13101539.
    Publicado • 10.3390/pharmaceutics13101539
  41. Egídio Freitas; Emma Guttman-Yassky; Tiago Torres. "Tralokinumab for the Treatment of Atopic Dermatitis". American Journal of Clinical Dermatology 22 5 (2021): 625-638. https://doi.org/10.1007/s40257-021-00613-8.
    10.1007/s40257-021-00613-8
  42. Melo, Amelia; Carrascosa, Jose Manuel; Torres, Tiago. "Baricitinib for the treatment of atopic dermatitis". Journal of Dermatological Treatment 33 5 (2021): 2404-2413. http://dx.doi.org/10.1080/09546634.2021.1967268.
    10.1080/09546634.2021.1967268
  43. Mahil, S.K.; Yates, M.; Yiu, Z.Z.N.; Langan, S.M.; Tsakok, T.; Dand, N.; Mason, K.J.; et al. "Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study". Journal of the European Academy of Dermatology and Venereology 35 10 (2021): http://dx.doi.org/10.1111/jdv.17450.
    10.1111/jdv.17450
  44. Teixeira, Ana; Teixeira, Maribel; Bento, Carmen; Azevedo, Luís Filipe; Vasconcelos, Viviana; Bahia, Maria Fernanda; Torres, Tiago; et al. "Patterns of dosage regimen instructions regarding topical medicines: how is the information perceived by patients?". Journal of Dermatological Treatment (2021): 1-6. http://dx.doi.org/10.1080/09546634.2021.1960262.
    Publicado • 10.1080/09546634.2021.1960262
  45. Bárbara Leal; Cláudia Carvalho; Ana Marta Ferreira; Miguel Nogueira; Sandra Brás; Berta M. Silva; Manuela Selores; Paulo P. Costa; Tiago Torres. "Serum Levels of miR-146a in Patients with Psoriasis". Molecular Diagnosis & Therapy (2021): https://doi.org/10.1007/s40291-021-00531-9.
    10.1007/s40291-021-00531-9
  46. Tiago Torres; Luis Puig; Ron Vender; Charles Lynde; Stefano Piaserico; Jose M. Carrascosa; Paolo Gisondi; et al. "Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study". American Journal of Clinical Dermatology 22 4 (2021): 567-579. https://doi.org/10.1007/s40257-021-00598-4.
    10.1007/s40257-021-00598-4
  47. Torres, Tiago; Pereira, Marta; Paiva Lopes, Maria João; Rebelo, Clarisse; Andrade, Pedro; Henrique, Martinha; Oliveira, Hugo; et al. "Dermatologists’ attitude towards psoriasis treatment during the COVID-19 pandemic". Drugs in Context 10 (2021): 1-9. http://dx.doi.org/10.7573/dic.2021-4-4.
    10.7573/dic.2021-4-4
  48. Freitas, Egídio; Torres, Tiago. "Bimekizumab: the new drug in the biologics armamentarium for psoriasis". Drugs in Context 10 (2021): 1-4. http://dx.doi.org/10.7573/dic.2021-4-1.
    10.7573/dic.2021-4-1
  49. Nogueira, Miguel; Selores, Manuela; Torres, Tiago. "A case of psoriasis and systemic lupus erythematous successfully treated with ustekinumab". European Journal of Dermatology 31 3 (2021): 429-431. http://dx.doi.org/10.1684/ejd.2021.4072.
    10.1684/ejd.2021.4072
  50. Miguel Nogueira; Amy S. Paller; Tiago Torres. "Targeted Therapy for Pediatric Psoriasis". Pediatric Drugs (2021): https://doi.org/10.1007/s40272-021-00443-5.
    10.1007/s40272-021-00443-5
  51. Gonçalves, Francisca; Freitas, Egídio; Torres, Tiago. "Selective IL-13 inhibitors for the treatment of atopic dermatitis". Drugs in Context 10 (2021): 1-17. http://dx.doi.org/10.7573/dic.2021-1-7.
    10.7573/dic.2021-1-7
  52. Mahil, S.K.; Yates, M.; Langan, S.M.; Yiu, Z.Z.N.; Tsakok, T.; Dand, N.; Mason, K.J.; et al. "Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey*". British Journal of Dermatology 185 1 (2021): 80-90. http://dx.doi.org/10.1111/bjd.19755.
    10.1111/bjd.19755
  53. Daniel G Oliveira; Raquel Faria; Tiago Torres. "An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far". Drug Design, Development and Therapy (2021): https://doi.org/10.2147/DDDT.S267405.
    10.2147/DDDT.S267405
  54. Torres, Tiago; Barcelos, Anabela; Filipe, Paulo; Fonseca, João Eurico. "A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains". Frontiers in Medicine 7 (2021): http://dx.doi.org/10.3389/fmed.2020.618163.
    10.3389/fmed.2020.618163
  55. Sandra Ferreira; Emma Guttman-Yassky; Tiago Torres. "Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib". American Journal of Clinical Dermatology (2020): https://doi.org/10.1007/s40257-020-00548-6.
    10.1007/s40257-020-00548-6
  56. Cohen, Arnon D.; Vender, Ronald; Naldi, Luigi; Kalb, Robert E.; Torres, Tiago; Rajagopalan, Murlidhar; van der Walt, Joelle; Puig, Lluís; Young, Helen S.. "Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council". JAAD International 1 2 (2020): 224-230. http://dx.doi.org/10.1016/j.jdin.2020.09.006.
    10.1016/j.jdin.2020.09.006
  57. Torres, Tiago; Tavares Bello, Rui; Paiva Lopes, Maria João; Menezes Brandão, Francisco; Ferreira, Ana; Ferreira, Paulo; Varela, Paulo; et al. "Portuguese recommendations for the treatment of psoriasis with biologic therapy". European Journal of Dermatology 30 6 (2020): 645-654. http://dx.doi.org/10.1684/ejd.2020.3945.
    10.1684/ejd.2020.3945
  58. Torres, Tiago. "Oral therapies for psoriasis and psoriatic arthritis: current knowledge and future perspectives". Giornale Italiano di Dermatologia e Venereologia 155 4 (2020): http://dx.doi.org/10.23736/s0392-0488.20.06712-7.
    10.23736/s0392-0488.20.06712-7
  59. M. Nogueira; R.B. Warren; T. Torres. "Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis – time for a paradigm change". Journal of the European Academy of Dermatology and Venereology (2020): https://doi.org/10.1111/jdv.16866.
    10.1111/jdv.16866
  60. Egídio Freitas; Maria Alexandra Rodrigues; Tiago Torres. "

    Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations

    ". Clinical, Cosmetic and Investigational Dermatology (2020): https://doi.org/10.2147/CCID.S240607.
    10.2147/CCID.S240607
  61. Tiago Torres; Luis Puig. "Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic". American Journal of Clinical Dermatology (2020): https://doi.org/10.1007/s40257-020-00514-2.
    10.1007/s40257-020-00514-2
  62. Silva, Maria Inês; Barbosa, Ana Isabel; Costa Lima, Sofia A.; Costa, Paulo; Torres, Tiago; Reis, Salette. "Freeze-Dried Softisan® 649-Based Lipid Nanoparticles for Enhanced Skin Delivery of Cyclosporine A". Nanomaterials 10 5 (2020): 986. http://dx.doi.org/10.3390/nano10050986.
    10.3390/nano10050986
  63. Nogueira, Miguel; Vender, Ron; Torres, Tiago. "Psoriasis, biologic therapy, and the pandemic of the 21st century". Drugs in Context 9 (2020): 1-4. http://dx.doi.org/10.7573/dic.2020-4-10.
    10.7573/dic.2020-4-10
  64. Ferreira, Sandra; Torres, Tiago. "Conjunctivitis in patients with atopic dermatitis treated with dupilumab". Drugs in Context 9 (2020): 1-8. http://dx.doi.org/10.7573/dic.2020-2-3.
    10.7573/dic.2020-2-3
  65. Ferreira, Clara; Azevedo, Alexandra; Nogueira, Miguel; Torres, Tiago. "Management of psoriasis in pregnancy – a review of the evidence to date". Drugs in Context 9 (2020): 1-9. http://dx.doi.org/10.7573/dic.2019-11-6.
    10.7573/dic.2019-11-6
  66. Miguel Nogueira; Luis Puig; Tiago Torres. "JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors". Drugs 80 4 (2020): 341-352. https://doi.org/10.1007/s40265-020-01261-8.
    10.1007/s40265-020-01261-8
  67. Rodrigues, M.A.; Torres, T.. "The Changing Landscape of Atopic Dermatitis - Focusing on JAK Inhibitors". European Annals of Allergy and Clinical Immunology 52 01 (2020): 45. http://dx.doi.org/10.23822/eurannaci.1764-1489.120.
    10.23822/eurannaci.1764-1489.120
  68. Ferreira, Sandra; Selores, Manuela; Torres, Tiago. "Neurofibromatose Tipo 1: Envolvimento Cutâneo Exuberante". N/a.. N/a. (2020): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12054.
    10.20344/amp.12054
  69. Rodrigues, Maria A.; Nogueira, Miguel; Torres, Tiago. "Dupilumab for atopic dermatitis: evidence to date". Giornale Italiano di Dermatologia e Venereologia 154 6 (2019): http://dx.doi.org/10.23736/s0392-0488.19.06417-4.
    10.23736/s0392-0488.19.06417-4
  70. Bosma, A.L.; Spuls, P.I.; Garcia-Doval, I.; Naldi, L.; Prieto-Merino, D.; Tesch, F.; Apfelbacher, C.J.; et al. "TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema". British Journal of Dermatology 182 6 (2019): 1423-1429. http://dx.doi.org/10.1111/bjd.18452.
    10.1111/bjd.18452
  71. Chiricozzi, Andrea; Balato, Anna; Conrad, Curdin; Conti, Andrea; Dapavo, Paolo; Ferreira, Paulo; Gaiani, Francesca Maria; et al. "Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study". Journal of Dermatological Treatment 31 5 (2019): 476-483. http://dx.doi.org/10.1080/09546634.2019.1671577.
    10.1080/09546634.2019.1671577
  72. Chiricozzi, Andrea; Torres, Tiago. "Reply to: “Comment on ‘Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study’”". Journal of the American Academy of Dermatology 81 3 (2019): e83. http://dx.doi.org/10.1016/j.jaad.2019.05.032.
    10.1016/j.jaad.2019.05.032
  73. Nogueira, Miguel; Torres, Tiago. "Guselkumab for the treatment of psoriasis – evidence to date". Drugs in Context 8 (2019): 1-11. http://dx.doi.org/10.7573/dic.212594.
    10.7573/dic.212594
  74. Torres, Tiago; Balato, Anna; Conrad, Curdin; Conti, Andrea; Dapavo, Paolo; Ferreira, Paulo; Gaiani, Francesca; et al. "Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study". Journal of the American Academy of Dermatology 81 1 (2019): 273-275. http://dx.doi.org/10.1016/j.jaad.2019.02.031.
    10.1016/j.jaad.2019.02.031
  75. Reis, Joel; Vender, Ron; Torres, Tiago. "Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis". BioDrugs 33 4 (2019): 391-399. http://dx.doi.org/10.1007/s40259-019-00361-6.
    10.1007/s40259-019-00361-6
  76. Oliveira, Clara; Torres, Tiago. "More than skin deep: the systemic nature of atopic dermatitis". European Journal of Dermatology 29 3 (2019): 250-258. http://dx.doi.org/10.1684/ejd.2019.3557.
    10.1684/ejd.2019.3557
  77. Rodrigues, Maria Alexandra; Torres, Tiago. "JAK/STAT inhibitors for the treatment of atopic dermatitis". Journal of Dermatological Treatment 31 1 (2019): 33-40. http://dx.doi.org/10.1080/09546634.2019.1577549.
    10.1080/09546634.2019.1577549
  78. Teixeira, A.; Vasconcelos, V.; Teixeira, M.; Almeida, V.; Azevedo, R.; Torres, T.; Sousa Lobo, J. M.; Costa, P. C.; Almeida, I. F.. "Mechanical Properties of Topical Anti-Psoriatic Medicines: Implications for Patient Satisfaction with Treatment". AAPS PharmSciTech 20 1 (2019): http://dx.doi.org/10.1208/s12249-018-1246-2.
    Publicado • 10.1208/s12249-018-1246-2
  79. Nogueira, Catarina Pinto; Torres, Tiago. "Placas Eritematosas Concêntricas Tipo Superfície de Madeira". N/a.. N/a. (2019): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/11075.
    10.20344/amp.11075
  80. Raposo, Inês; Bettencourt, Andreia; Leite, Luiz; Selores, Manuela; Torres, Tiago. "Ustekinumab in Real-Life Practice: Experience in 116 Patients with Moderate-To-Severe Psoriasis". (2019): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10728.
    10.20344/amp.10728
  81. Vasconcelos, V.; Teixeira, A.; Almeida, V.; Teixeira, M.; Ramos, S.; Torres, T.; Sousa Lobo, J. M.; Almeida, I. F.. "Patient preferences for attributes of topical anti-psoriatic medicines". Journal of Dermatological Treatment 30 7 (2018): 659-663. http://dx.doi.org/10.1080/09546634.2018.1544410.
    Publicado • 10.1080/09546634.2018.1544410
  82. Machado, Álvaro; Torres, Tiago. "Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date". Psoriasis: Targets and Therapy Volume 8 (2018): 83-92. http://dx.doi.org/10.2147/ptt.s165943.
    10.2147/ptt.s165943
  83. Torres, T.. "Inhibidores selectivos de la IL-23: los recién llegados al tratamiento de la psoriasis". Actas Dermo-Sifiliográficas 109 8 (2018): 674-676. http://dx.doi.org/10.1016/j.ad.2018.03.016.
    10.1016/j.ad.2018.03.016
  84. Azevedo, Alexandra; Bettencourt, Andreia; Selores, Manuela; Torres, Tiago. "Biosimilar Agents for Psoriasis Treatment: The Perspective of Portuguese Patients". Acta Médica Portuguesa 31 9 (2018): 496-500. http://dx.doi.org/10.20344/amp.10127.
    10.20344/amp.10127
  85. Rita S, Matos; Tiago, Torres. "Photo Rounds: Rapid-onset rash in child.". The Journal of family practice 67 (2018):
  86. Torres, Tiago; Filipe, Paulo; Basto, Artur Sousa; Fernandes, José Carlos; Ferreira, Ana; Rosmaninho, Aristóteles; Pereira, Marta; et al. "The DRAGON study: biologic DRug survivAl in PortuGuese psOriasis patieNts". European Journal of Dermatology 28 5 (2018): 685-687. http://dx.doi.org/10.1684/ejd.2018.3353.
    10.1684/ejd.2018.3353
  87. Queirós, N.; Torres, T.. "Psoriasis asociada al VIH". Actas Dermo-Sifiliográficas 109 4 (2018): 303-311. http://dx.doi.org/10.1016/j.ad.2017.09.014.
    10.1016/j.ad.2017.09.014
  88. Ferreira, S.; Torres, T.. "Dupilumab para el tratamiento de la dermatitis atópica". Actas Dermo-Sifiliográficas 109 3 (2018): 230-240. http://dx.doi.org/10.1016/j.ad.2017.10.012.
    10.1016/j.ad.2017.10.012
  89. Pereira, R.; Raposo, I.; Nery, F.; Torres, T.. "Risk of hepatitis B virus reactivation in patients treated with anti-TNFa agents for immune-mediated inflammatory diseases". Actas Dermo-Sifiliográficas 109 3 (2018): 285-287. http://dx.doi.org/10.1016/j.ad.2017.07.011.
    10.1016/j.ad.2017.07.011
  90. Machado, Álvaro; Torres, Tiago. "Guselkumab for the Treatment of Psoriasis". BioDrugs 32 2 (2018): 119-128. http://dx.doi.org/10.1007/s40259-018-0265-6.
    10.1007/s40259-018-0265-6
  91. Alexandra Azeveo; Tiago Torres. "The successful treatment with ixekizumab in a multifailure psoriasis patient.". Dermatology online Journal 10 24 (9) (2018): 130.
  92. Rita S, Matos; Tiago, Torres. "Erythematous, Scaly Rash After Sun Exposure.". American family physician 96 (2017):
  93. Azevedo, Alexandra; Torres, Tiago. "Tofacitinib: A New Oral Therapy for Psoriasis". Clinical Drug Investigation 38 2 (2017): 101-112. http://dx.doi.org/10.1007/s40261-017-0596-y.
    10.1007/s40261-017-0596-y
  94. Ferreira, Mara; Barreiros, Luísa; Segundo, Marcela A.; Torres, Tiago; Selores, Manuela; Costa Lima, Sofia A.; Reis, Salette. "Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: A targeted approach for psoriasis management". Colloids and Surfaces B: Biointerfaces 159 (2017): 23-29. http://dx.doi.org/10.1016/j.colsurfb.2017.07.080.
    10.1016/j.colsurfb.2017.07.080
  95. Torres, Tiago. "Atopic Dermatitis: The New Therapeutic Revolution in Dermatology". Acta Médica Portuguesa 30 10 (2017): 669-670. http://dx.doi.org/10.20344/amp.9787.
    10.20344/amp.9787
  96. Pereira, Rui; Faria, Raquel; Lago, Paula; Torres, Tiago. "Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases". Current Drug Safety 12 3 (2017): http://dx.doi.org/10.2174/1574886312666170616085228.
    10.2174/1574886312666170616085228
  97. Raposo, Inês; Carvalho, Cláudia; Bettencourt, Andreia; Da Silva, Berta Martins; Leite, Luiz; Selores, Manuela; Torres, Tiago. "Psoriasis pharmacogenetics: HLA-Cw*0602 as a marker of therapeutic response to ustekinumab". European Journal of Dermatology 27 5 (2017): 528-530. http://dx.doi.org/10.1684/ejd.2017.3071.
    10.1684/ejd.2017.3071
  98. Torres, Tiago. "Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab". Drugs 77 14 (2017): 1493-1503. http://dx.doi.org/10.1007/s40265-017-0794-1.
    10.1007/s40265-017-0794-1
  99. Raposo, Inês; Bettencourt, Andreia; Selores, Manuela; Torres, Tiago. "Awareness and screening attitudes of Portuguese dermatologists on cardiovascular risk factors in psoriatic patients". European Journal of Dermatology 27 4 (2017): 443-445. http://dx.doi.org/10.1684/ejd.2017.3053.
    10.1684/ejd.2017.3053
  100. Torres, Tiago; Puig, Luis. "Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis". American Journal of Clinical Dermatology 19 1 (2017): 23-32. http://dx.doi.org/10.1007/s40257-017-0302-0.
    10.1007/s40257-017-0302-0
  101. Relvas, Maria; Torres, Tiago. "Pediatric Psoriasis". American Journal of Clinical Dermatology 18 6 (2017): 797-811. http://dx.doi.org/10.1007/s40257-017-0294-9.
    10.1007/s40257-017-0294-9
  102. Azevedo, Alexandra; Gonçalves, Cristina; Selores, Manuela; Torres, Tiago. "Remission of psoriasis after autologous stem cell transplantation - until when?". European Journal of Dermatology 27 1 (2017): 74-75. http://dx.doi.org/10.1684/ejd.2016.2893.
    10.1684/ejd.2016.2893
  103. Mota, Fernando; Neves, Esmeralda; Oliveira, José Carlos; Selores, Manuela; Torres, Tiago. "Importance of immunogenicity testing for cost-effective management of psoriasis patients treated with adalimumab". Acta Dermatovenerologica Alpina Pannonica et Adriatica 26 2 (2017): http://dx.doi.org/10.15570/actaapa.2017.10.
    10.15570/actaapa.2017.10
  104. A. Azevedo; T. Torres. "Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis". Actas Dermo-Sifiliográficas (2016): https://doi.org/10.1016%2Fj.ad.2016.09.021.
    10.1016/j.ad.2016.09.021
  105. Rita S, Matos; Tiago, Torres. "Facial hair growth in a patient with psoriasis.". Australian family physician 45 (2016):
  106. Tiago Torres; Ana Ferreira; Paulo Ferreira; Martinha Henriques; Luiz Leite; Sofia Magina; Gabriela Marques Pinto; et al. "Portuguese Position Paper on the Use of Biosimilars in Psoriasis". Acta Médica Portuguesa 29 9 (2016): 574-574. https://doi.org/10.20344%2Famp.8118.
    10.20344/amp.8118
  107. Chiricozzi, Andrea; Romanelli, Marco; Saraceno, Rosita; Torres, Tiago. "No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents". Expert Opinion on Drug Safety 15 12 (2016): 1653-1659. http://dx.doi.org/10.1080/14740338.2016.1228872.
    10.1080/14740338.2016.1228872
  108. F. Mota; M. Selores; T. Torres. "Importance of educational sessions on cardiometabolic comorbidities. Awareness among psoriasis patients". Actas Dermo-Sifiliográficas (English Edition) 107 6 (2016): 539-541. https://doi.org/10.1016%2Fj.adengl.2015.12.004.
    10.1016/j.adengl.2015.12.004
  109. Torres, T.; Romanelli, M.; Chiricozzi, A.. "A revolutionary therapeutic approach for psoriasis: bispecific biological agents". Expert Opinion on Investigational Drugs 25 7 (2016): 751-754. http://dx.doi.org/10.1080/13543784.2016.1187130.
    10.1080/13543784.2016.1187130
  110. Carla, Ferreira da Silva; Tiago, Torres. "Development of erythematous scaly lesions in a cervical surgical scar.". Australian family physician 45 (2016):
  111. Teixeira, Ana; Teixeira, Maribel; Almeida, Vera; Torres, Tiago; Sousa Lobo, José Manuel; Almeida, Isabel Filipa. "Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment". Journal of Dermatological Science 82 2 (2016): 63-68. http://dx.doi.org/10.1016/j.jdermsci.2016.02.008.
    Publicado • 10.1016/j.jdermsci.2016.02.008
  112. Joana, Tendais-Almeida; Fátima, Fátima Aguiar; Tiago, Torres. "Nail pitting and onycholysis.". Australian family physician 45 (2016):
  113. Inês Raposo; Tiago Torres. "Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects". American Journal of Clinical Dermatology 17 4 (2016): 349-358. https://doi.org/10.1007%2Fs40257-016-0191-7.
    10.1007/s40257-016-0191-7
  114. Rafael, Adilia; Torres, Tiago. "Topical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors". European Journal of Dermatology 26 1 (2016): 3-8. http://dx.doi.org/10.1684/ejd.2015.2663.
    10.1684/ejd.2015.2663
  115. Tiago Torres; Inês Raposo; Manuela Selores. "IL-17 Blockade in Psoriasis: Friend or Foe in Cardiovascular Risk?". American Journal of Clinical Dermatology 17 2 (2015): 107-112. https://doi.org/10.1007%2Fs40257-015-0166-0.
    10.1007/s40257-015-0166-0
  116. Pereira, Rui; Lago, Paula; Faria, Raquel; Torres, Tiago. "Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy". Drug Development Research 76 8 (2015): 419-427. http://dx.doi.org/10.1002/ddr.21285.
    10.1002/ddr.21285
  117. Inês Raposo; Tiago Torres. "Psoriasis strikes back! Epicardial adipose tissue: Another contributor to the higher cardiovascular risk in psoriasis". Revista Portuguesa de Cardiologia 34 10 (2015): 613-616. https://doi.org/10.1016%2Fj.repc.2015.04.007.
    10.1016/j.repc.2015.04.007
  118. Torres, Tiago; Faria, Raquel. "Ustekinumab: The “New Kid on the Block” in the Treatment of Psoriatic Arthritis". Drug Development Research 76 8 (2015): 428-431. http://dx.doi.org/10.1002/ddr.21279.
    10.1002/ddr.21279
  119. Tiago Torres; Paulo Filipe. "Small Molecules in the Treatment of Psoriasis". Drug Development Research 76 5 (2015): 215-227. https://doi.org/10.1002%2Fddr.21263.
    10.1002/ddr.21263
  120. I. Raposo; T. Torres. "Nail psoriasis as a predictor of the development of psoriatic arthritis". Actas Dermo-Sifiliográficas 106 6 (2015): 452-457. https://doi.org/10.1016%2Fj.ad.2015.02.005.
    10.1016/j.ad.2015.02.005
  121. Torres, Tiago; Bettencourt, Nuno; Ferreira, Joana; Carvalho, Cláudia; Mendonça, Denisa; Vasconcelos, Carlos; Selores, Manuela; Silva, Berta. "Lack of association between leptin, leptin receptor, adiponectin gene polymorphisms and epicardial adipose tissue, abdominal visceral fat volume and atherosclerotic burden in psoriasis patients". Archives of Physiology and Biochemistry 121 3 (2015): 103-108. http://dx.doi.org/10.3109/13813455.2015.1024136.
    10.3109/13813455.2015.1024136
  122. T. Torres; L. Puig. "Treatment goals for psoriasis: Should PASI 90 become the standard of care?". Actas Dermo-Sifiliográficas (English Edition) 106 3 (2015): 155-157. https://doi.org/10.1016%2Fj.adengl.2014.10.005.
    10.1016/j.adengl.2014.10.005
  123. Bettencourt, Andreia; Carvalho, Cláudia; Leal, Bárbara; Brás, Sandra; Lopes, Dina; Martins da Silva, Ana; Santos, Ernestina; et al. "The Protective Role of HLA-DRB1*13 in Autoimmune Diseases". Journal of Immunology Research 2015 (2015): 1-6. http://dx.doi.org/10.1155/2015/948723.
    10.1155/2015/948723
  124. Torres, T.; Bettencourt, N.; Ferreira, J.; Carvalho, C.; Mendonça, D.; Pinho-Costa, P.; Vasconcelos, C.; Selores, M.; Silva, B.. "Influence of interleukin-6 gene polymorphisms in epicardial adipose tissue and coronary artery calcification in patients with psoriasis". British Journal of Dermatology 172 2 (2014): 534-536. http://dx.doi.org/10.1111/bjd.13271.
    10.1111/bjd.13271
  125. Torres, T.; Bettencourt, N.; Ferreira, J.; Carvalho, C.; Mendonça, D.; Pinho-Costa, P.; Vasconcelos, C.; Selores, M.; Silva, B.. "Influence of TNF-a gene polymorphisms in coronary artery calcification in psoriasis patients". Journal of the European Academy of Dermatology and Venereology 30 1 (2014): 191-193. http://dx.doi.org/10.1111/jdv.12706.
    10.1111/jdv.12706
  126. Cabete, Joana; Torres, Tiago; Vilarinho, Tiago; Ferreira, Ana; Selores, Manuela. "Erectile dysfunction in psoriasis patients". European Journal of Dermatology 24 4 (2014): 482-486. http://dx.doi.org/10.1684/ejd.2014.2388.
    10.1684/ejd.2014.2388
  127. Bernardo, Correia; Tiago, Torres. "Obesity: a key component of psoriasis.". Acta bio-medica : Atenei Parmensis 86 (2014):
  128. Tiago Torres; Nuno Bettencourt; Denisa Mendonça; Carlos Vasconcelos; Berta Martins Silva; Manuela Selores. "Complement C3 as a marker of cardiometabolic risk in psoriasis". Archives of Dermatological Research 306 7 (2014): 653-660. https://doi.org/10.1007%2Fs00403-014-1467-5.
    10.1007/s00403-014-1467-5
  129. Torres, T.; Bettencourt, N.; Mendonça, D.; Vasconcelos, C.; Gama, V.; Silva, B.M.; Selores, M.. "Epicardial adipose tissue and coronary artery calcification in psoriasis patients". Journal of the European Academy of Dermatology and Venereology 29 2 (2014): 270-277. http://dx.doi.org/10.1111/jdv.12516.
    10.1111/jdv.12516
  130. Teresa Pinto-Almeida; Tiago Torres. "Biologic therapy for psoriasis - still searching for the best target". Anais Brasileiros de Dermatologia 89 2 (2014): 365-367. https://doi.org/10.1590%2Fabd1806-4841.20142898.
    10.1590/abd1806-4841.20142898
  131. Tiago Torres; Paulo Filipe. "Interleucina-17 como Alvo Terapêutico na Psoríase". Acta Médica Portuguesa 27 2 (2014): 252-252. https://doi.org/10.20344%2Famp.4777.
    10.20344/amp.4777
  132. Torres, Tiago; Machado, Susana; Mendonça, Denisa; Selores, Manuela. "Cardiovascular comorbidities in childhood psoriasis". European Journal of Dermatology 24 2 (2014): 229-235. http://dx.doi.org/10.1684/ejd.2014.2291.
    10.1684/ejd.2014.2291
  133. Torres T; Bettencourt N; Tiago Torres; Nuno Bettencourt. "Psoriasis: The visible killer.". Revista Portuguesa de Cardiologia (English Edition) 33 2 (2014): 95-99. http://europepmc.org/abstract/med/24525359.
    10.1016/j.repc.2013.06.017
  134. Torres T; Alexandre JM; Mendonça D; Vasconcelos C; Silva BM; Selores M. "Levels of Physical Activity in Patients with Severe Psoriasis: A Cross-Sectional Questionnaire Study.". (2014): http://europepmc.org/abstract/med/24464933.
  135. Rita Sales; Tiago Torres. "Psoriasis and metabolic syndrome". Acta Dermatovenerologica Croatia 22 3 (2014): 169-174.
  136. Pinto-Almeida T; Torres T; Sanches M; Selores M. "Treatment of palmoplantar pustulosis with ustekinumab - the importance of interfering with the IL23/Th17 pathway.". (2013): http://europepmc.org/abstract/med/24280259.
    10.1684/ejd.2013.2196
  137. Vilaça S; Torres T; Selores M. "Sacroiliitis in a psoriasis patient after switching from etanercept to ustekinumab.". (2013): http://europepmc.org/abstract/med/24192318.
    10.1684/ejd.2013.2179
  138. Torres T; Sales R; Vasconcelos C; Martins da Silva B; Selores M. "Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: Implications in cardiovascular risk factors management and primary prevention of cardiovascular disease.". (2013): http://europepmc.org/abstract/med/24128349.
    10.1111/1346-8138.12267
  139. Torres T; Chiricozzi A; Chimenti S; Saraceno R. "Genetic Markers for Cardiovascular Disease in Psoriasis: The Missing Piece.". (2013): http://europepmc.org/abstract/med/24078347.
    10.1007/s40291-013-0056-1
  140. Fernandes IC; Torres T; Selores M. "Maintenance treatment of psoriasis with cyclosporine A: comparison between continuous and weekend therapy.". (2013): http://europepmc.org/abstract/med/23317974.
    10.1016/j.jaad.2012.08.013
  141. Marina Papoutsaki; Filipa Osório; Paulo Morais; Tiago Torres; Sofia Magina; Sergio Chimenti; Antonio Costanzo. "Infliximab in Psoriasis and Psoriatic Arthritis". BioDrugs 27 S1 (2013): 13-23. https://doi.org/10.1007%2Fbf03325638.
    10.1007/bf03325638
  142. Pinto-Almeida T; Torres T; Selores M. "Multiple myeloma in a patient under ustekinumab--are they related?". (2013): http://europepmc.org/abstract/med/23985266.
    10.1684/ejd.2013.2096
  143. Torres T; Sales R; Vasconcelos C; Selores M. "[Psoriasis and cardiovascular disease].". (2013): http://europepmc.org/abstract/med/24192101.
  144. Torres T; Filipe P; Selores M. "Impact of biosimilars in psoriasis treatment.". (2013): http://europepmc.org/abstract/med/24388249.
  145. Saraceno R; Specchio F; Torres T; Nisticò SP; Rizza S; Chimenti S. "The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study.". (2012): http://europepmc.org/abstract/med/22507590.
    10.1016/j.jaad.2011.06.008
  146. Torres T; Velho G; Sanches M; Selores M. "A case of erythrokeratodermia variabilis with connexin 31 gene mutation (Cx31F137L).". (2012): http://europepmc.org/abstract/med/21913904.
    10.1111/j.1365-4632.2010.04640.x
  147. Saggini A; Chiricozzi A; Torres T. "Dusky red swelling of the penis in association with fever and diarrhoea: a quiz. Metastatic Crohn's disease of the penis associated with enteric Crohn's disease.". (2012): http://europepmc.org/abstract/med/22102067.
    10.2340/00015555-1263
  148. Torres T; Fernandes I; Selores M; Alves R; Lima M. "Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues.". (2012): http://europepmc.org/abstract/med/22177649.
    10.1016/j.jaad.2011.01.016
  149. Torres T; Selores M. "Does treatment of metabolic syndrome components improve psoriasis? Report of three cases.". (2012): http://europepmc.org/abstract/med/22257905.
    10.1684/ejd.2011.1614
  150. Torres T; Vilaça S; Velho G; Selores M. "Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab.". (2012): http://europepmc.org/abstract/med/22910198.
    10.1684/ejd.2012.1816
  151. Fernandes IC; Torres T; Sanches M; Velho G; Lago P; Selores M. "[Psoriasis induced by infliximab].". (2011): http://europepmc.org/abstract/med/22856418.
  152. Torres T; Pinto Almeida T; Alves R; Sanches M; Selores M. "Treatment of recalcitrant generalized granuloma annulare with adalimumab.". (2011): http://europepmc.org/abstract/med/22134573.
  153. Feldmeyer, Laurence; Guenova, Emmanuella; Torres, Tiago; Nosbaum, Audrey. "Residents’ corner September 2011. Residents’ editorial choice". European Journal of Dermatology 21 5 (2011): 826-827. http://dx.doi.org/10.1684/ejd.2011.1502.
    10.1684/ejd.2011.1502
  154. Feldmeyer L; Guenova E; Torres T; Nosbaum A. "Residents'corner July 2011.". (2011): http://europepmc.org/abstract/med/21865120.
    10.1684/ejd.2011.1485
  155. Feldmeyer L; Guenova E; Torres T; Nosbaum A. "Residents'corner July 2011.". (2011): http://europepmc.org/abstract/med/21865118.
    10.1684/ejd.2011.1483
  156. Torres T; Oliveira A; Sanches M; Selores M. "Superficial cutaneous leiomyosarcoma of the face: report of three cases.". (2011): http://europepmc.org/abstract/med/21352334.
    10.1111/j.1346-8138.2010.01105.x
  157. Torres, T.; Fernandes, I.; Sanches, M.; Selores, M.. "Foscarnet-induced penile ulceration". JAMA Dermatology 159 (2011): 1129.
    Acesso aberto
  158. Torres, T.; Fernandes, I.; Costa, V:; Selores, M.. "Photodynamic therapy as adjunctive therapy for morpheaform basal cell carcinoma". (2011):
    Acesso aberto
  159. Feldmeyer L; Guenova E; Torres T; Nosbaum A. "Residents'corner May 2011.". (2011): http://europepmc.org/abstract/med/21715248.
    10.1684/ejd.2011.1425
  160. Saggini A; Torres T. "Residents' corner September 2011. sQUIZ your knowledge!". (2011): http://europepmc.org/abstract/med/21933754.
    10.1684/ejd.2011.1503
  161. Torres T; Guenova E; Feldmeyer L; Nosbaum A. "Residents' corner November 2011. Residents' editorial choice.". (2011): http://europepmc.org/abstract/med/22231910.
    10.1684/ejd.2011.1605
  162. Pinto-Almeida T; Torres T; Sanches M; Alves R; Selores M. "Granuloma annulare of the penis - subcutaneous presentation.". (2011): http://europepmc.org/abstract/med/21543288.
    10.1684/ejd.2011.1353
  163. Pinto-Almeida T; Torres T; Rosmaninho A; Sanches M; Alves R; Caetano M; Selores M. "Letter: Penile Kaposi sarcoma: A case of complete resolution with highly active antiretroviral therapy alone.". (2011): http://europepmc.org/abstract/med/21696692.
  164. Torres, T.; Rosmaninho, A.; Caetano, M.; Selores, M.. "Malignant melanoma misdiagnosed as a diabetic foot ulcer". Diabetic Medicine 27 11 (2010): 1302-1303. http://dx.doi.org/10.1111/j.1464-5491.2010.03102.x.
    10.1111/j.1464-5491.2010.03102.x
  165. Tiago Torres; Manuela Selores. "Tratamento de hidradenite supurativa com infliximab". Anais Brasileiros de Dermatologia 85 4 (2010): 576-576. https://doi.org/10.1590%2Fs0365-05962010000400028.
    10.1590/s0365-05962010000400028
  166. Torres T; Caetano M; Alves R; Horta M; Selores M. "Tender tumor of the scalp: clinicopathologic challenge. Primary cutaneous adenoid cystic carcinoma.". (2010): http://europepmc.org/abstract/med/20618463.
    10.1111/j.1365-4632.2009.04426.x
  167. Tiago Torres; Glória Cunha Velho; Manuela Selores. "Poroceratose superficial disseminada num doente com colangiocarcinoma: manifestação paraneoplásica?". Anais Brasileiros de Dermatologia 85 2 (2010): 229-231. https://doi.org/10.1590%2Fs0365-05962010000200016.
    10.1590/s0365-05962010000200016
  168. Tiago Torres; Susana Machado; Manuela Selores. "Woolly hair generalizado: caso clínico e revisão da literatura". Anais Brasileiros de Dermatologia 85 1 (2010): 97-100. https://doi.org/10.1590%2Fs0365-05962010000100016.
    10.1590/s0365-05962010000100016
  169. Torres T; Velho GC; Selores M. "Disseminated superficial porokeratosis in a patient with cholangiocarcinoma: a paraneoplastic manifestation?". (2010): http://europepmc.org/abstract/med/20520941.
    10.1590/S0365-05962010000200016
  170. Rosmaninho A; Torres T; Velho G; Lopes V; Amorim I; Selores M. "Paecilomyces lilacinus in transplant patients: an emerging infection.". (2010): http://europepmc.org/abstract/med/20610372.
    10.1684/ejd.2010.1032
  171. Torres T; Selores M. "Treatment of hidradenitis suppurativa with infliximab.". (2010): http://europepmc.org/abstract/med/20944927.
    10.1590/S0365-05962010000400028
  172. Torres T; Velho GC; Sanches M; Selores M. "[Psoriasis in the era of biologics].". (2010): http://europepmc.org/abstract/med/20654269.
  173. Torres T; Machado S; Velho G; Selores M. "Isolated tongue lesions as the sole presentation of secondary syphilis.". (2010): http://europepmc.org/abstract/med/20123647.
    10.1684/ejd.2010.0919
  174. Torres T; Velho G; Alves R; Selores M. "Widespread comedones as the sole clinical manifestation of follicular mycosis fungoides.". (2010): http://europepmc.org/abstract/med/20413371.
    10.1684/ejd.2010.0988
  175. Tiago Torres; Madalena Sanches; Manuela Selores. "IgA bullous disease in a patient with Crohn’s disease.". Acta Dermatovenerologica Alpina, PAnnonica et Adriatica 19 1 (2010): 29-31.
  176. Lobo, I; Torres, T; Pina, F; Dominguez, M; Alves, R; Barbas do Amaral, J; Selores, M. "Plexiform schwannoma of the lip mucosa". Journal of the European Academy of Dermatology and Venereology 23 5 (2009): 616-618. http://dx.doi.org/10.1111/j.1468-3083.2008.03057.x.
    10.1111/j.1468-3083.2008.03057.x
  177. Torres T; Ferreira M; Sanches M; Selores M. "Pemphigus vegetans in a patient with colonic cancer.". (2009): http://europepmc.org/abstract/med/19915243.
    10.4103/0378-6323.57724
Capítulo de livro
  1. Nogueira, Miguel; Tiago Torres. "Inibidores da IL-23". In Hot topics psoríase – Terapêuticas Biológicas. 2023.
  2. Egídio Freitas; Torres, Tiago. "Tratamento sistémico da dermatite atópica". In Hot topics Dermatite Atópica. 2023.
  3. Sandra Ferreira; Tiago Torres. "Demodecidosis". In Therapeutics in Dermatology. 2016.
Pré-impressão
  1. Tiago Torres. "Complementary Use of a Next-Generation Emollient Plus and Pimecrolimus in Atopic Dermatitis: A Case Report". 2023. https://doi.org/10.20944/preprints202307.0971.v1.
    10.20944/preprints202307.0971.v1
Revisão de livro
  1. Torres, Tiago; Ferreira, Eduarda Osório; Gonçalo, Margarida; Mendes-Bastos, Pedro; Selores, Manuela; Filipe, Paulo. "Update on Atopic Dermatitis". https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/11963.
    10.20344/amp.11963
  2. Torres, Tiago; Henrique, Martinha; Oliveira, Hugo; Rodrigues, Madalena; Ferreira, Paulo; Morais, Paulo; Alves, Sérgio; Lopes, Tiago Castro; Cernadas, Rui. "Management of Psoriasis by Family Physicians: Referral Algorithm and Shared Management with Dermatology". https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13159.
    10.20344/amp.13159

Outros

Norma ou política
  1. Member of the Scientific Committee that drafted the Guideline "Norma Clínica da DGS nº065/2011 (30/12/201)1" for the treatment of PSoriasis in Non-Pediatric Age wih biologic Agents. 2011. Torres, Tiago.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2022 Cardiometabolic Syndrome - Where Do Dermatologists Fit In International Psoriasis Council – European Academy of Dermatology and Venereology
2022 Psoriasis pathogenesis - an update Immunodermatology Day
2022 Horizon views of Psoriasis Skin Inflammation & Psoriasis International Network Congress
2022 Screening and Follow-up - biologic therapies International Psoriasis Council – Regional Master Class Latin America
2022 JAK inhibitors in atopic dermatitis Skin Inflammation & Psoriasis International Network Congress
2022 How to manage difficult-to-treat locations European Academy of Dermatology and Venereology
2021 Psoriasis: differential diagnosis and pitfalls European Academy of Dermatology and Venereology
2021 Psoriasis treatments: Review and Updates European Academy of Dermatology and Venereology
2021 Is there a need to look for comorbidities in psoriasis? European Academy of Dermatology and Venereology
2021 Psoriasis comorbidities 6th Annual Meeting of the Egyptian Society for Psoriasis.
2020 What is playing it safe in paediatric psoriasis? European Academy of Dermatology and Venereology
2019 Hot topics and challenging cases in psoriasis: A focus on biosimilars, disease severity, drug survival and systemic therapies. International Psoriasis Council – European Academy of Dermatology and Venereology.
2019 Psoriasis comorbidities Skin Inflammation & Psoriasis International Network Congress
2018 Case-base learning workshop: comorbidities & complications - Cardiometabolic comorbidities International Psoriasis Council - Regional Master Class
2017 Avanços terapêuticos no Lúpus Eritematoso Cutâneo Congresso da Sociedade Portuguesa de Dermatologia e Venereologia
Sociedade Portuguesa de Dermatologia e Venereologia
2017 Biologic agents in psoriasis Current treatments in Dermatology
2016 How to choose the optimal systemic treatment European Academy of Dermatology and Venereology
2016 Vitamin D and combinations with glucocorticosteroids European Academy of Dermatology and Venereology
2016 Biologics & Biosimilars. Extrapolating the evidence. A multidisciplinary approach Congresso da Associação Portuguesa de Farmacêuticos Hospitalares
2016 Pipeline small molecules & biosimilars XI Curso Terapéutica Biológica/Inmunológica en Dermatología
2015 Metabolic complications of psoriasis European Academy of Dermatology and Venereology
2015 Psoriasis and Cardiovascular disease PsoFuture
2015 O espectro de comorbilidades na doença psoriática Curso sobre Psoríase
2015 O futuro da terapêutica – novas moléculas Curso sobre Psoríase
2014 Psoriasis and cardiometabolic comorbidities Porto’s Autoimmune Meeting
2013 Fisiopatologia da psoríase e comorbilidades associadas Congresso da Sociedade Portuguesa de Dermatologia e Venereologia
2013 Asma induzida por inibidor TNF com resolução após transição para Ustekinumab Encontro Nacional de Psoríase
2012 Tratamento da Psoríase Congresso da Sociedade Portuguesa de Dermatologia e Venereologia

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2022 - Atual Impacto da epigenética na Psoríase
Orientador de Miguel Filipe de Oliveira Nogueira
 Ciências Médicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021 - Atual Patient centric design of topical medicines for rare dermatological diseases
Coorientador de Ana Cristina Ramos Torres
 Ciências Farmacêuticas (Doutoramento)
Universidade do Porto Faculdade de Farmácia, Portugal
2019 - Atual Atopic dermatitis - early determinants and long term effect
Orientador de Maria Alexandra Leão de Magalhães Rodrigues
 Saúde Pública (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2021 - 2022 Generalized pustular psoriasis: the new era of treatment with IL-36 inhibitors
Orientador de Cláudia Oliveira Maçães
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021 - 2022 Consequências Cutâneas dos Fármacos Inibidores de Pontos de Restrição Imunológicos
Orientador de Bianca Souto da Silva Oliveira
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021 - 2022 The role of Tapinarof in the treatment of Psoriasis
Orientador de Sofia Jacques de Nogueira
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021 - 2022 Deucravacitinib in the treatment of psoriasis
Orientador de Tomás Miguel Estevinho Alves Martins
Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 - 2021 Dermatite Atópica: impacto na qualidade de vida
Orientador de Ana Filipa Rodrigues Iglésias Ferreira
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 - 2021 Baricitinib for the treatment of Atopic Dermatitis
Orientador de Amélia do Céu Vicente Fontes e Melo
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 - 2021 O uso tópico da ivermectina 1% no tratamento da Rosácea
Orientador de Mariana Isabel Neves da Cruz
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 - 2021 A Relação entre Psoríase e Tabaco
Orientador de Cátia Sofia Cunha da Silva
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 - 2021 Nail disease beyond onychomycosis
Coorientador de Ana Mafalda Paiva Pais
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 - 2021 Rosácea
Coorientador de Helena Isabel Moreira Carvalho
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 - 2021 Reações cutâneas medicamentosas graves
Coorientador de Teresa Rocha de Oliveira
Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019 - 2020 Efeito da perda ponderal na gravidade da psoríase em doentes obesos
Orientador de Mariana Martins Moreira de Sá
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019 - 2020 Os inibidores seletivos da IL-13 no tratamento da dermatite atópica
Orientador de Maria Francisca Cristo de Salgado Gonçalves
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017 - 2018 The role of methotrexate in the treatment of psoriasis
Orientador de Filipa Emanuel de Castro Gouveia
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017 - 2018 Atopic dermatitis: a systemic disease
Orientador de Ana Clara Marques Oliveira
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017 - 2018 Psoriasis and chronic obstructive pulmonary disease
Orientador de Catarina Gil Azevedo Ribeiro
Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2017 The effects of psoriasis on diastolic (Dys) Function - A pilot echocardiographic
Orientador de Ana Rita da Silva Veiga
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2017 Tratamento da Psoríase em doentes com Hepatite C
Orientador de Alexandra Mesquita Pinto da Rocha
Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2017 Mês de Nascimento e Risco de Psoríase
Orientador de Ana Isabel Gomes Martins
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2017 Abordagem terapêutica tópica da Psoriase ligeira a moderada no adulto
Orientador de Cátia Sofia Resende Pereira
Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2017 Immunopathogenesis of psoriasis
Orientador de Anabela Ribeiro Faria de Carvalho
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2017 Treatment of HIV-associated psoriasis
Orientador de Nuno Brochado Pinto da Silva Queirós
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015 - 2016 Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy
Orientador de Rui Miguel Pedrosa Pereira
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015 - 2016 Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy
Orientador de Filipa Carreira Mendes Andrade
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015 - 2016 Pediatric Psoriasis
Orientador de Marta Vieira Relvas
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013 - 2014 Psoríase e riscos de doença Cardiovascular
Orientador de Ana Rita de Jesus Sales
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013 - 2014 Psoríase e Obesidade
Orientador de Bernardo José Teixeira Correia
Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013 - 2014 A influência das doenças / lesões dermatológicas nas impressões digitais - caraterísticas e alterações
Orientador
 Medicina Legal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2020 - Atual Uma manhã com a Psoríase. Evento anual para doentes e familiares (2020)
Encontro (Coorganizador)
2018 - Atual "Uma manhã com a Psoríase" is an annual educational event for patients with psoriasis and their families. Organized in collaboration with the Portuguese Patients Association PSO (2018)
2018 - Atual "Uma manhã com a Dermatite Atópica" is an annual educational event for patients with atopic dermatitis and their families. Organized in collaboration with the Portuguese Patients Association ADERMAP (2018)
2024/01/13 - 2024/01/13 Immunodermatology day 2024 (2024/01/13 - 2024/01/13)
2022/01/15 - 2022/01/15 Immunodermatology Day (2022/01/15 - 2022/01/15)
Simpósio

Júri de grau académico

Tema
Tipo de participação 		Nome do candidato (Tipo de grau)
Instituição / Organização
2022/12/19 Carcinoma Basocelular da Cabeça e Pescoço: Caracterização de Alterações Moleculares e Identificação de Fatores de Risco na População de Trás-os-Montes e Alto Douro.
Vogal
 António Luís Pires Castanheira (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2022/07/13 Tinea capitis: Um problema pediátrico atual
Presidente do júri
 Miguel Rodrigues de Sousa Martins (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/06/18 Psicodermatoses
Presidente do júri
 Afonso de Almeida Tété Machado (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020/07/08 Weekend nonvariceal acute upper gastrointestinal bleeding - an additional risk?
Presidente do júri
 João Ricardo Neves da Cruz (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020/07/08 The clinical impact of Rockall and Glasgow-Blatchford scores in nonvariceal upper gastrointestinal bleeding
Presidente do júri
 Susana Maria Ferreira Maia (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019/07/10 Seguimentos de doentes com doença hepática avançada após cura do vírus C.
Presidente do júri
 Pedro Duarte Fragoso (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/07/19 Abordagem cirúrgica miniinvasiva para o tratamento da patologia valvular aórtica. A experiência do Centro Hospitalar Vila Nova de Gaia/Espinho EPE
Presidente do júri
 António Maria Pereira Rodrigues Ferreira da Silva (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/07/13 Inflammatory parental nutrition-associated disease
Presidente do júri
 Maria Teresa Pina Vaz Gonçalves Rodrigues (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/07/06 Associação entre dermatite atópica infantil e perturbação de hiperatividade/défice de atenção: estudo corte retrospetivo em crianças portuguesas.
Arguente
 Vitor João Queirós Coelho (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/07/05 Fisiopatologia da fibrilhação auricular
Presidente do júri
 Ana Cláudia Mendes Duarte (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/07/05 Carcinoma diferenciado da tiroide: avaliação dos fatores de prognóstico
Presidente do júri
 Rita Calejo Pereira Machado Ribeiro (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/07/15 Fisiopatologia da Alopécia Areata
Arguente
 Luís Miguel Gonçalves Ribeiro (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015/07/24 Onicomicose e Psoríase ungueal
Arguente
 Pedro Miguel Moura Guedes da Costa Silva (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015/07/06 Síndroma metabólica e doença cardiovascular na artrite psoriática - Artigo de revisão bibliográfica
Arguente
 Isabel Pinto Oliveira (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014/07/18 Síndroma metabólica e doença cardiovascular na artrite psoriática - Artigo de revisão bibliográfica
Arguente
 Rui Jorge de Freitas da Silva (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2021 - Atual Member of the Editorial Board of Journal of IMIDS
2021 - Atual Member of the Editorial Board of Journal of International Medical Research
2021 - Atual Specialty Chief Editor of Frontiers in Drug Discovery (section Dermatological Drugs)
2020 - Atual Co-editor of the journal Potuguese Journal of Dermatology and Venereology
2019 - Atual Associate Editor of the journal Drugs in Context
2019 - Atual Member of the Editorial Board of the Journal Drugs
2017 - Atual Associate Editor of the journal Acta Médica Portuguesa
2016 - Atual Member of the Editorial Board for the e-book "Therapeutics in Dermatology" da Fondation René Touraine
2015 - 2020 Associate Editor of the Revista da Sociedade Portugesa de Dermatologia e Venereologia
2010 - 2012 Member of the Editorial Board of the journal European Journal of Dermatology

Membro de associação

Nome da associação Tipo de participação
2024 - Atual European Dermatology Forum (EDF)
2023 - Atual President of the Skin Inflammation and Psoriasis International Network (SPIN)
2021 - Atual International Eczema Council (IEC)
2021 - Atual Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
2020 - Atual Skin Inflammation & Psoriasis International Network (SPIN)
2018 - Atual International Psoriasis Council (IPC)
2012 - Atual European Society of Cutaneous Lupus Erythematosus
2010 - Atual International Dermoscopy Association
2009 - Atual European Academy of Dermatology and Venereology
2006 - Atual Sociedade Portuguesa de Dermatologia e Venereologia (SPDV)

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2023 - Atual Principal Investigator in the clinical trial FLEX-UP: A Phase 3b/4 Randomized, Double-blind, Dose-Flexibility Study of Upadacitinib in Adult Subjects with Moderate to Severe Atopic Dermatitis (Flex-Up) (Phase IIIb/IV Trial)
2023 - Atual Principal Investigator in the clinical trial LEVEL-UP: A Phase 3b/4 Randomized, Open-label, Efficacy Assessor Blinded Study, Comparing the Safety and Assessor Blinded Efficacy of Upadacitinib to Dupilumab in Subjects with Moderate to Severe Atopic Dermatitis (Level- -Up) (Phase IIIb/IV Trial).
2023 - Atual Principal Investigator in the clinical trial ROCKET-Horizon: A Phase 3, Randomized, 24-week, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (Phase III Trial).
2023 - Atual Principal Investigator in the clinical trial ROCKET-Ignite (Protocol 20210142): A Phase 3, 24-week, Randomized, Placebo- controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (Phase III Trial).
2022 - Atual Principail Investigator in the clinical trial APOLO (Protocol B7451081): APOLO: AtoPic dermatitis – a cross sectionaL study on disease characteristics and impact On patients (Non-interventional study).
2020 - Atual Founding Member of the Atopic Dermatitis Reflection and Analysis Group of the SPDV
2020 - Atual Principal Investigator in the clinical trial PsoHo: “Psoriasis Study of Health Outcomes (PSoHO) – an International Observational Study of 3-Year Health Outcomes in the Biologic Treatment of Moderate-to-Severe Plaque Psoriasis” (Phase IV Trial).
2020 - Atual Principal Investigator in the clinical trial GLOBOSTAD: “A Prospective Observational Study Of Adult Patients Receiving Dupixent For Atopic Dermatitis” (Phase IV Trial)
2009 - Atual Principal Investigator in the clinical trial PSOLAR®: A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics; (Phase IV Trial)
2009 - Atual Principal Investigator in the clinical trial MEASURE UP 2: A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis (Phase III Trial).
2023 - 2025 President of the Fiscal Council of SPDV
2019 - 2022 President of the Psoriasis Portuguese Group from SPDV
2012 - 2022 Principal Investigator in the clinical trial: AMAGINE-2 (Amgen 20120103): A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis
2012 - 2022 Principal Investigator in the clinical trial: EPI: Estudo do Impacto da Psoríase moderada/grave em Portugal; (Phase IV Trial).
2012 - 2022 Principal Investigator in the clinical trial: EPIC: Eficácia do Adalimumab em doentes com Psoríase em Placas moderada a grave com co-morbilidades distintas; (Phase IV Trial)
2012 - 2022 Principal Investigator in the clinical trial: GESTURE (CAIN457A2312): A randomized double blind, placebo-controlled, multicenter study to demonstrate the efficacy at 16 weeks of Secukinumab 150 and 300 mg s.c and to assess safety, tolerability and long-term efficacy up to 80 weeks in subjects with moderate to severe palmoplantar psoriasis; (Phase III Trial).
2012 - 2022 Principal Investigator in the Clinical Trial: CLEAR (CAIN457A2317): A 52-week, multicenter, randomized, double-blind study of subcutaneous Secukinumab to demonstrate efficacy as assessed by Psoriasis Area and Severity Index at 16 weeks of treatment compared to Ustekinumab and to assess long-term safety, tolerability and efficacy in subjects with moderate to severe plaque psoriasis; (Phase III Trial
2012 - 2022 Principal Investigator in the Clinical Trial: OPTIMISE: Long Term Clear Skin Maintenance Treatment Optimization in Patients with Moderate to Severe Chronic Plaque Psoriasis: A Randomized, Multicenter, Open-label With Blinded-assessment, Comparative, 52 Week Study to Evaluate the Efficacy, Safety and Tolerability of Secukinumab 300 mg s.c.; (Phase III Trial)
2012 - 2022 Principal Investigator in the clinical trial: iMMvent: BI 655066/ABBV-066: Risankizumab Versus Adalimumab in a Randomized, Double Blind, Parallel Group Trial in Moderate to Severe Plaque Psoriasis to Assess Safety and Efficacy After 16 Weeks of Treatment and After Inadequate Adalimumab Treatment Response; (Phase III Trial).
2012 - 2022 Principal Investigator in the clinical trial UltIMMa-2: BI 655066 Versus Ustekinumab and Placebo Comparators in a Randomized Double-Blind trial for Maintenance Use in Moderate to Severe Plaque Type Psoriasis; (Phase III Trial).
2012 - 2022 Principal Investigator in the Clinical Trial PROSE: An Open-label, Prospective, Non-randomized, Multicenter Study to Evaluate Clear Skin Effect on Health-Related Quality of Life Outcomes at 16 and 52 Weeks in Patients with Moderate to Severe Plaque Psoriasis Treated with Secukinumab 300 mg s.c. With or Without Previous Exposure to Systemic Therapy; (Phase IV Trial)
2012 - 2022 Principal investigator in the clinical trial LIMMITLESS: A Multicenter, open-label study to assess the safety and efficacy of rIsankizuMab for MaInTenance in moderate to severe pLaquE type pSoria- Sis-; (Phase III Trial).
2012 - 2022 Principal Investigator in the clinical trial SERENA: A long-term, observational, prospective study to collect in a real-life setting data on the retention, effectiveness, safety, treatment pattern, quality of life (QoL), and efficiency of Secukinumab in adult patients with moderate to severe plaque psoriasis; (Phase IV Trial).
2012 - 2022 Principal Investigator in the Clinical trial QALIPSO: “A prospective observational study to evaluate the quality of life in patients with plaque psoriasis treated with Enstilar® for the first time” (Phase IV Trial).
2020 - 2020 Member of the EADV Task Force for Psoriasis
Distinções

Prémio

2022 Prémio Janssen Immunology Real World Evidence Award 2012
2020 Melhor Comunicação oral 1º <Congresso virtual de dermatologia e venereologia
Sociedade Portuguesa de Dermatologia e Venereologia, Portugal
2019 Prémio Janssen Immunology Real World Evidence Award 2019
2017 Prémio Janssen Immunology Real World Evidence Award 2017:
2016 Melhor Comunicação Oral do 15º Congresso Nacional de Dermatologia e Venereologia

Outra distinção

2023 Bolsa Juvenal Esteves
2021 Bolsa de Investigação SPDV-Sanofi
2019 Bolsa de Investigação Juvenal Esteves
2019 Bolsa de Investigação SPDV-Sanofi
2017 Bolsa Juvenal Esteves
Sociedade Portuguesa de Dermatologia e Veneorologia, Portugal
2017 Bolsa Juvenal Esteves
2013 Bolsa Juvenal Esteves
Sociedade Portuguesa de Dermatologia e Veneorologia, Portugal
2011 Bolsa de Apoio a Teses de Doutoramento
Centro Hospitalar Universitário do Porto EPE, Portugal
2010 Bolsa de Investigação Juvenal Esteves